Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
The New England Journal of Medicine|November 1, 2016
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery DiseaseGregg W Stone, Joseph F Sabik, Patrick W Serruys, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 30, 2025
Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trialNorman Mangner, Samin K Sharma, Chris O'Connor, et al.
European Heart Journal|April 2, 2025
Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trialDidier Tchetche, Philippe Pibarot, Jeroen J Bax, et al.
Journal of the American College of Cardiology|September 18, 2020
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelDavide Capodanno, Marie-Claude Morice, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|March 8, 2023
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19Gregg W Stone, Michael E Farkouh, Anuradha Lala, et al.
European Heart Journal|November 4, 2021
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trialRafael Romaguera, Pablo Salinas, Josep Gomez-Lara, et al.
The New England Journal of Medicine|September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial InfarctionVijay Kunadian, Helen Mossop, Carol Shields, et al.
The New England Journal of Medicine|August 13, 2016
Sharing Data from Cardiovascular Clinical Trials--A Proposal, Manesh R Patel, Paul W Armstrong, et al.
European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.
Nature Medicine|December 5, 2022
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-PreservedStefan D Anker, Javed Butler, Muhammad Shariq Usman, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
The New England Journal of Medicine|November 1, 2016
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery DiseaseGregg W Stone, Joseph F Sabik, Patrick W Serruys, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 30, 2025
Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trialNorman Mangner, Samin K Sharma, Chris O'Connor, et al.
European Heart Journal|April 2, 2025
Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trialDidier Tchetche, Philippe Pibarot, Jeroen J Bax, et al.
Journal of the American College of Cardiology|September 18, 2020
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelDavide Capodanno, Marie-Claude Morice, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|March 8, 2023
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19Gregg W Stone, Michael E Farkouh, Anuradha Lala, et al.
European Heart Journal|November 4, 2021
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trialRafael Romaguera, Pablo Salinas, Josep Gomez-Lara, et al.
The New England Journal of Medicine|September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial InfarctionVijay Kunadian, Helen Mossop, Carol Shields, et al.
The New England Journal of Medicine|August 13, 2016
Sharing Data from Cardiovascular Clinical Trials--A Proposal, Manesh R Patel, Paul W Armstrong, et al.
European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.
Nature Medicine|December 5, 2022
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-PreservedStefan D Anker, Javed Butler, Muhammad Shariq Usman, et al.
Pageof 35